Vitamin C (CAS 50-81-7): Mechanism, Benchmarks, and Research Use

Executive Summary: Vitamin C (ascorbic acid) is a water-soluble vitamin with a molecular formula of C6H8O6 and a molecular weight of 176.12. It exhibits dose-dependent antiproliferative and pro-apoptotic effects on tumor cells, notably CT26 murine colon cancer models (see APExBIO product page). In vitro and in vivo studies confirm its efficacy in reducing tumor volume and in ameliorating cellular senescence by modulating the ROS/NF-κB pathway (Xu et al., 2024). The compound is highly soluble in water (≥57.9 mg/mL) and is rigorously quality-controlled, making it suitable for advanced cancer and aging research workflows. Recent articles extend mechanistic understanding and practical guidance for bench and translational research, specifically utilizing APExBIO's high-purity Vitamin C (CAS 50-81-7).

Biological Rationale

Vitamin C is an essential micronutrient involved in redox homeostasis, collagen biosynthesis, and cellular signaling. It is classified as a water-soluble vitamin due to its polar structure, facilitating rapid dissolution and distribution in biological systems (APExBIO product information). Deficiency is linked to impaired immune response, poor wound healing, and increased oxidative stress. In aging populations, oxidative stress and chronic inflammation drive tissue senescence and dysfunction, with Vitamin C deficiency correlated with increased morbidity (Xu et al., 2024). The compound's potent antioxidant capabilities enable it to quench reactive oxygen species (ROS), thereby reducing cellular senescence and supporting tissue homeostasis.

Mechanism of Action of Vitamin C (CAS 50-81-7)

Vitamin C exerts multifaceted effects in biological systems:

• Direct ROS scavenging: Ascorbic acid donates electrons to neutralize ROS, mitigating oxidative damage in cells (Xu et al., 2024).
• NF-κB pathway modulation: By reducing ROS, Vitamin C attenuates phosphorylation of NF-κB p65, thereby downregulating expression of pro-inflammatory cytokines and senescence markers such as p21.
• Anticancer activity: In tumor models, Vitamin C inhibits proliferation and induces apoptosis via dose-dependent mechanisms—showing significant effects at concentrations from 100–1000 μg/mL in CT26 and 4T1 cell lines (APExBIO product data).

These mechanisms underlie its applications as an anticancer agent and apoptosis inducer, as well as its protective effects in age-related hearing loss and cellular senescence models.

Evidence & Benchmarks

• Vitamin C at 100–200 μg/mL significantly inhibited proliferation of CT26 colon cancer cells in vitro (APExBIO product information).
• Concentrations of 200–1000 μg/mL induced apoptosis in CT26 cells, demonstrating a dose-response relationship (APExBIO product information).
• In vivo administration reduced tumor volume in both CT26 and 4T1 tumor-bearing BALB/c mouse models (APExBIO product information).
• Vitamin C ameliorated D-galactose-induced senescence in HEI-OC1 cochlear hair cells by inhibiting ROS accumulation and NF-κB activation (Xu et al., 2024).
• Dietary Vitamin C intake is associated with improved hearing outcomes in aging populations (Xu et al., 2024).

For a deeper mechanistic and translational perspective, see this Immuneland review, which contrasts with the present article by focusing on organoid-based antiviral models and broader translational workflows.

Applications, Limits & Misconceptions

Vitamin C (CAS 50-81-7) is widely used as an experimental anticancer agent, apoptosis inducer, and for studies on cellular senescence and oxidative stress. Its solubility profile—≥57.9 mg/mL in water, ≥12.2 mg/mL in ethanol (ultrasonic), and ≥5.8 mg/mL in DMSO—enables flexible protocol integration (APExBIO product details). The compound is also applied in aging research related to hearing loss, as demonstrated in HEI-OC1 models (Xu et al., 2024).

Common Pitfalls or Misconceptions

• Vitamin C does not function as a universal cytoprotective agent—high concentrations can induce cell death in certain tumor cell types.
• Stability of Vitamin C solutions is limited; long-term storage of prepared solutions leads to degradation and loss of efficacy (APExBIO).
• Results from murine or in vitro cancer models may not directly translate to human therapeutic outcomes due to species-specific pharmacokinetics.
• Vitamin C's anti-senescence effects are context-dependent, with efficacy demonstrated primarily in oxidative stress-induced models.
• Not all antioxidants replicate the specific ROS/NF-κB pathway inhibition observed with Vitamin C (Xu et al., 2024).

This article updates prior summaries such as Vitamin C (CAS 50-81-7): Mechanistic and Translational Be... by providing new peer-reviewed data on senescence and direct evidence for ROS/NF-κB pathway modulation.

Workflow Integration & Parameters

• Solubility: Prepare solutions at ≥57.9 mg/mL in water at room temperature; use ultrasonic assistance for ethanol (≥12.2 mg/mL).
• Storage: Store solid Vitamin C at -20°C; avoid long-term storage of solutions, as decomposition occurs at ambient temperatures (APExBIO).
• Assay concentrations: For antiproliferative and apoptosis assays, use 100–1000 μg/mL based on target cell line sensitivity (APExBIO).
• Quality control: Use product lots with ≥98% purity, confirmed by HPLC and NMR analysis.
• Senescence studies: For D-galactose-induced models, treat HEI-OC1 cells with Vitamin C for 24 h post-senescence induction (Xu et al., 2024).

APExBIO's B2064 kit provides validated documentation and batch traceability. For further workflow optimization in cell assays, see this protocol-focused article, which this dossier extends by detailing recent advances in senescence and tumor biology.

Conclusion & Outlook

Vitamin C (CAS 50-81-7) has robust, reproducible effects as an anticancer agent, apoptosis inducer, and modulator of cellular senescence via ROS/NF-κB inhibition, supported by recent peer-reviewed and product data. APExBIO offers a high-purity, quality-controlled preparation suitable for mechanistic and translational research. Cross-domain evidence from hearing loss and cancer models suggests a promising but context-dependent application landscape. Ongoing studies should clarify its translational potential and precise protocol parameters for emerging model systems. For further mechanistic insights, see this tumor and organoid models review, which this article updates by integrating anti-senescence and hearing loss data.